Peter Keith Isquith, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Executive Function | 13 | 2021 | 1263 | 1.790 |
Why?
|
| Neuropsychological Tests | 20 | 2021 | 6814 | 0.910 |
Why?
|
| Personality Assessment | 3 | 2014 | 702 | 0.690 |
Why?
|
| Child Behavior | 4 | 2014 | 898 | 0.590 |
Why?
|
| Problem Solving | 4 | 2006 | 436 | 0.560 |
Why?
|
| Brain Injuries | 4 | 2014 | 1819 | 0.560 |
Why?
|
| Memory, Short-Term | 5 | 2018 | 924 | 0.480 |
Why?
|
| Cognition Disorders | 7 | 2014 | 3942 | 0.380 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2014 | 633 | 0.360 |
Why?
|
| Severity of Illness Index | 5 | 2013 | 16227 | 0.340 |
Why?
|
| Adolescent Behavior | 2 | 2014 | 1265 | 0.330 |
Why?
|
| Psychometrics | 7 | 2009 | 2954 | 0.320 |
Why?
|
| Post-Concussion Syndrome | 1 | 2009 | 217 | 0.310 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 5 | 2014 | 4092 | 0.300 |
Why?
|
| Aptitude Tests | 1 | 2005 | 17 | 0.300 |
Why?
|
| Social Control, Informal | 2 | 2005 | 50 | 0.300 |
Why?
|
| Dichotic Listening Tests | 1 | 2004 | 22 | 0.300 |
Why?
|
| Social Adjustment | 2 | 2004 | 672 | 0.270 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2014 | 6389 | 0.270 |
Why?
|
| Language Development Disorders | 1 | 2004 | 172 | 0.260 |
Why?
|
| Concept Formation | 1 | 2004 | 147 | 0.250 |
Why?
|
| Child Behavior Disorders | 3 | 2005 | 881 | 0.230 |
Why?
|
| Behavior | 1 | 2004 | 584 | 0.220 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2021 | 75 | 0.220 |
Why?
|
| Auditory Perception | 1 | 2004 | 523 | 0.200 |
Why?
|
| Parents | 6 | 2021 | 3093 | 0.200 |
Why?
|
| Brain Damage, Chronic | 1 | 2000 | 269 | 0.200 |
Why?
|
| Athletic Injuries | 1 | 2009 | 1117 | 0.190 |
Why?
|
| Social Environment | 1 | 2004 | 1042 | 0.180 |
Why?
|
| Brain Concussion | 1 | 2008 | 1152 | 0.170 |
Why?
|
| Emotions | 4 | 2015 | 2319 | 0.170 |
Why?
|
| Child | 19 | 2021 | 71361 | 0.150 |
Why?
|
| Child, Preschool | 9 | 2021 | 41159 | 0.140 |
Why?
|
| Adolescent | 16 | 2021 | 84957 | 0.120 |
Why?
|
| Factor Analysis, Statistical | 2 | 2013 | 991 | 0.120 |
Why?
|
| Tourette Syndrome | 1 | 2014 | 398 | 0.120 |
Why?
|
| Adolescent Development | 1 | 2015 | 286 | 0.110 |
Why?
|
| Reproducibility of Results | 6 | 2014 | 19308 | 0.110 |
Why?
|
| Hyperkinesis | 1 | 2010 | 102 | 0.100 |
Why?
|
| Awareness | 1 | 2014 | 590 | 0.100 |
Why?
|
| Decision Making | 1 | 2004 | 3865 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2014 | 1394 | 0.090 |
Why?
|
| Models, Psychological | 1 | 2013 | 845 | 0.090 |
Why?
|
| Self Disclosure | 1 | 2009 | 271 | 0.090 |
Why?
|
| Memory Disorders | 2 | 2010 | 1118 | 0.080 |
Why?
|
| Child Reactive Disorders | 1 | 2005 | 11 | 0.080 |
Why?
|
| Developmental Disabilities | 2 | 2005 | 1424 | 0.070 |
Why?
|
| Humans | 27 | 2021 | 686663 | 0.070 |
Why?
|
| Foster Home Care | 1 | 2005 | 108 | 0.070 |
Why?
|
| Reference Values | 2 | 2004 | 5134 | 0.070 |
Why?
|
| Self-Assessment | 1 | 2006 | 392 | 0.070 |
Why?
|
| Socialization | 1 | 2004 | 95 | 0.070 |
Why?
|
| Reaction Time | 1 | 2010 | 2115 | 0.060 |
Why?
|
| Survivors | 1 | 2014 | 2033 | 0.060 |
Why?
|
| Frontal Lobe | 1 | 2010 | 1432 | 0.060 |
Why?
|
| Attention | 2 | 2010 | 2388 | 0.060 |
Why?
|
| Patient Care Planning | 1 | 2008 | 951 | 0.060 |
Why?
|
| Checklist | 1 | 2009 | 756 | 0.060 |
Why?
|
| Internal-External Control | 1 | 2004 | 365 | 0.060 |
Why?
|
| Affective Symptoms | 1 | 2005 | 418 | 0.060 |
Why?
|
| Child Development | 1 | 2014 | 2279 | 0.060 |
Why?
|
| Fenfluramine | 1 | 2021 | 62 | 0.060 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2005 | 490 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3797 | 0.050 |
Why?
|
| Teaching | 1 | 2009 | 1213 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2008 | 2659 | 0.050 |
Why?
|
| Injury Severity Score | 1 | 2004 | 1018 | 0.050 |
Why?
|
| Forecasting | 1 | 2009 | 2956 | 0.050 |
Why?
|
| Male | 16 | 2018 | 352465 | 0.050 |
Why?
|
| Reference Standards | 1 | 2021 | 891 | 0.050 |
Why?
|
| Female | 16 | 2018 | 375459 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2004 | 6685 | 0.040 |
Why?
|
| Health Status | 1 | 2009 | 4011 | 0.040 |
Why?
|
| Epilepsies, Partial | 1 | 2018 | 393 | 0.030 |
Why?
|
| Adaptation, Psychological | 1 | 2004 | 2464 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2018 | 21684 | 0.030 |
Why?
|
| Cranial Irradiation | 1 | 1995 | 434 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2010 | 6549 | 0.030 |
Why?
|
| Young Adult | 3 | 2021 | 56052 | 0.030 |
Why?
|
| Anticonvulsants | 1 | 2021 | 1875 | 0.030 |
Why?
|
| Intelligence | 1 | 1995 | 931 | 0.030 |
Why?
|
| Seizures | 1 | 2021 | 2410 | 0.020 |
Why?
|
| Aging | 1 | 2006 | 8222 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2014 | 60991 | 0.020 |
Why?
|
| Age of Onset | 1 | 2014 | 3373 | 0.020 |
Why?
|
| Personality Development | 1 | 2005 | 265 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3687 | 0.020 |
Why?
|
| Social Behavior | 1 | 2009 | 1127 | 0.020 |
Why?
|
| Self Report | 1 | 2013 | 3341 | 0.010 |
Why?
|
| Dyslexia | 1 | 2002 | 255 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 13603 | 0.010 |
Why?
|
| Logistic Models | 1 | 2014 | 13807 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2010 | 7791 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2004 | 67320 | 0.010 |
Why?
|
| Cognition | 1 | 2014 | 5582 | 0.010 |
Why?
|
| Age Factors | 1 | 2014 | 19295 | 0.010 |
Why?
|
| Psychotherapy | 1 | 2005 | 1522 | 0.010 |
Why?
|
| Injections, Spinal | 1 | 1995 | 307 | 0.010 |
Why?
|
| Affect | 1 | 2002 | 1497 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 1995 | 8590 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 1995 | 522 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1995 | 11115 | 0.010 |
Why?
|
| Autistic Disorder | 1 | 2002 | 1024 | 0.010 |
Why?
|
| Cytarabine | 1 | 1995 | 683 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2005 | 2940 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1995 | 1531 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 8926 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1995 | 677 | 0.010 |
Why?
|
| Adult | 3 | 2013 | 211400 | 0.010 |
Why?
|
| Palliative Care | 1 | 2005 | 3093 | 0.010 |
Why?
|
| Time Factors | 1 | 2014 | 42271 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 3365 | 0.010 |
Why?
|
| Methotrexate | 1 | 1995 | 1677 | 0.010 |
Why?
|
| Radiotherapy | 1 | 1995 | 1674 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2005 | 21640 | 0.000 |
Why?
|
| Middle Aged | 2 | 2010 | 216468 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 33186 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2005 | 39737 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1995 | 9114 | 0.000 |
Why?
|
| Sex Factors | 1 | 1995 | 10926 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 59331 | 0.000 |
Why?
|
| Aged | 1 | 2006 | 162271 | 0.000 |
Why?
|